Please Wait...

Mélanie Bodnar-Wachtel

Translation skills

Main profile

Mélanie Bodnar-Wachtel, PhD
Mélanie Bodnar-Wachtel, PhD
Scientific Expert and Sales Support Specialist

Dr. Mélanie Bodnar-Wachtel is Scientific Expert for Biochemical Markers at Bioclinica Lab and is responsible for neurosciences and oncology projects.  Drawing on her experience in academic and industry research, she is dedicated to bringing innovative solutions to the development of new technologies for biomarker assessment and in expanding Bioclinica Lab's biomarker portfolio.  She earned a PhD in Sciences, specialty Molecular, Integrative and Cellular Biology from Université de Lyon, France, and a Master's degree in Biology and Health, specialty Oncogenesis, from École Pratique des Hautes Études, France.

Blogs

The Alzheimer's and Parkinson's Diseases scientific and medical community gathered at the AAT-AD/PD Focus Meeting in March to share the latest research and clinical advances.

The use of biomarkers is expanding across all stages in the drug development process, helping bring about new and innovative practices in the treatment of many diseases, including Alzheimer's and cancer. With their ability to revolutionize development of advanced therapeutics, biomarkers have become essential tools.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Still time to catch up on summer reading on recent developments in #Alzheimer's Disease Fluid Biomarkers here int t… https://t.co/kyQmz7FxlN
bioclinica (2 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still other organizations remain… https://t.co/UwVs6ajPp4
bioclinica (3 days ago)
Our clients have substantial success w #eSource, some spanning well over a decade. Still some in the industry remai… https://t.co/ASuUvN6xb9
bioclinica (5 days ago)
RT @RfwrightLSL: When Do You Think #BYOD (Bring Your Own Device) Will Become Widely Used To Capture PRO Data In #Clinical #Research? https:…
bioclinica (2 weeks ago)
ICYMI: Our V.P./Head of Neuroscience & Cardiovascular Svcs., Dr. Joyce Suhy, talks about challenges in determining… https://t.co/Lns6B3VPPN
bioclinica (2 weeks ago)
RT @FCR_News_Today: FDA Issues New Guides on Use of Electronic Health Information in #ClinicalTrials. #ClinicalResearch https://t.co/j8LHV2…
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen